Skip to main content

Walleye Capital LLC

Position in EOLS — Evolus, Inc.

CIK 1758720 NEW YORK, NY

Position in EOLS

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$1,761,489
+$877,239 QoQ
Shares Held
253,817
+90.9% QoQ
Ownership
0.384%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 157 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Derivatives in EOLS

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$694
PutShares
100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $47,294,180 across 23 Drug Manufacturers - Specialty & Generic names. EOLS ranks #7 (3.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 EOLS
Evolus, Inc.
This page
253,817 $1,761,489

All Filings in EOLS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $694 100
2026-06-30 $1,761,489 253,817
2025-12-31 $54,530 8,200
2025-12-31 $109,060 16,400
2025-12-31 $884,250 132,970
2025-09-30 $24,560 4,000
2025-09-30 $414,450 67,500
2025-09-30 $75,073 12,227
2025-06-30 $827,979 89,900
2025-06-30 $921 100
2025-06-30 $136,694 14,842
2025-03-31 $475,160 39,498
2024-12-31 $327,888 29,700
2024-12-31 $33,120 3,000
2024-12-31 $3,005,617 272,248
2024-09-30 $3,437,785 212,209
2024-03-31 $53,200 3,800
2024-03-31 $61,600 4,400
2024-03-31 $2,980,446 212,889
2023-12-31 $2,463,504 233,951
2023-09-30 $2,678,787 293,084
2023-06-30 $269,506 37,071
2023-06-30 $14,540 2,000
2022-03-31 $221,460 19,738
2021-09-30 $106,977 14,039
2020-03-31 $276,390 66,600